| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $14.54B | -1.0% |
| Cost of Revenue | $13.57B | -1.4% |
| Gross Profit | $961.0M | +3.6% |
| R&D Expense | $387.0M | +4.0% |
| SG&A Expense | $522.0M | +3.0% |
| Operating Income | $115.0M | -66.5% |
| Interest Expense | $183.0M | -2.1% |
| Pre-tax Income | -$88.0M | -166.2% |
| Income Tax | $103.0M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.87B | -1.2% |
| Inventory | $695.0M | -8.3% |
| Current Assets | $4.13B | +1.2% |
| Total Assets | $8.95B | -4.2% |
| Current Liabilities | $3.69B | +0.2% |
| Long-term Debt | $2.39B | -0.4% |
| Stockholders' Equity | $1.77B | -17.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $449.0M | -17.3% |
| Investing Cash Flow | -$186.0M | +26.5% |
| Financing Cash Flow | -$267.0M | +46.8% |
| +221.9% |
| Net Income | -$281.0M | -1661.1% |
| EPS (Basic) | -$3.39 | -1795.0% |
| EPS (Diluted) | -$3.39 | -1795.0% |